\documentclass[11pt,twoside]{article}\makeatletter \IfFileExists{xcolor.sty}% {\RequirePackage{xcolor}}% {\RequirePackage{color}} \usepackage{colortbl} \usepackage{wrapfig} \usepackage{ifxetex} \ifxetex \usepackage{fontspec} \usepackage{xunicode} \catcode`⃥=\active \def⃥{\textbackslash} \catcode`❴=\active \def❴{\{} \catcode`❵=\active \def❵{\}} \def\textJapanese{\fontspec{Noto Sans CJK JP}} \def\textChinese{\fontspec{Noto Sans CJK SC}} \def\textKorean{\fontspec{Noto Sans CJK KR}} \setmonofont{DejaVu Sans Mono} \else \IfFileExists{utf8x.def}% {\usepackage[utf8x]{inputenc} \PrerenderUnicode{–} }% {\usepackage[utf8]{inputenc}} \usepackage[english]{babel} \usepackage[T1]{fontenc} \usepackage{float} \usepackage[]{ucs} \uc@dclc{8421}{default}{\textbackslash } \uc@dclc{10100}{default}{\{} \uc@dclc{10101}{default}{\}} \uc@dclc{8491}{default}{\AA{}} \uc@dclc{8239}{default}{\,} \uc@dclc{20154}{default}{ } \uc@dclc{10148}{default}{>} \def\textschwa{\rotatebox{-90}{e}} \def\textJapanese{} \def\textChinese{} \IfFileExists{tipa.sty}{\usepackage{tipa}}{} \fi \def\exampleFont{\ttfamily\small} \DeclareTextSymbol{\textpi}{OML}{25} \usepackage{relsize} \RequirePackage{array} \def\@testpach{\@chclass \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else \ifnum \@lastchclass=7 5 \else \ifnum \@lastchclass=8 \tw@ \else \ifnum \@lastchclass=9 \thr@@ \else \z@ \ifnum \@lastchclass = 10 \else \edef\@nextchar{\expandafter\string\@nextchar}% \@chnum \if \@nextchar c\z@ \else \if \@nextchar l\@ne \else \if \@nextchar r\tw@ \else \z@ \@chclass \if\@nextchar |\@ne \else \if \@nextchar !6 \else \if \@nextchar @7 \else \if \@nextchar (8 \else \if \@nextchar )9 \else 10 \@chnum \if \@nextchar m\thr@@\else \if \@nextchar p4 \else \if \@nextchar b5 \else \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi} \gdef\arraybackslash{\let\\=\@arraycr} \def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}} \def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}} \def\abbr{} \def\corr{} \def\expan{} \def\gap{} \def\orig{} \def\reg{} \def\ref{} \def\sic{} \def\persName{}\def\name{} \def\placeName{} \def\orgName{} \def\textcal#1{{\fontspec{Lucida Calligraphy}#1}} \def\textgothic#1{{\fontspec{Lucida Blackletter}#1}} \def\textlarge#1{{\large #1}} \def\textoverbar#1{\ensuremath{\overline{#1}}} \def\textquoted#1{‘#1’} \def\textsmall#1{{\small #1}} \def\textsubscript#1{\@textsubscript{\selectfont#1}} \def\textxi{\ensuremath{\xi}} \def\titlem{\itshape} \newenvironment{biblfree}{}{\ifvmode\par\fi } \newenvironment{bibl}{}{} \newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par } \newenvironment{citbibl}{}{\ifvmode\par\fi } \newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi } \newenvironment{docDate}{}{\ifvmode\par\fi } \newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi } \newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par } \newenvironment{msHead}{\vskip 6pt}{\par} \newenvironment{msItem}{\vskip 6pt}{\par} \newenvironment{rubric}{}{} \newenvironment{titlePart}{}{\par } \newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}} \newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}} \newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}} \newcolumntype{P}[1]{){\arraybackslash}p{#1}} \newcolumntype{B}[1]{){\arraybackslash}b{#1}} \newcolumntype{M}[1]{){\arraybackslash}m{#1}} \definecolor{label}{gray}{0.75} \def\unusedattribute#1{\sout{\textcolor{label}{#1}}} \DeclareRobustCommand*{\xref}{\hyper@normalise\xref@} \def\xref@#1#2{\hyper@linkurl{#2}{#1}} \begingroup \catcode`\_=\active \gdef_#1{\ensuremath{\sb{\mathrm{#1}}}} \endgroup \mathcode`\_=\string"8000 \catcode`\_=12\relax \usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry} \usepackage{framed} \definecolor{shadecolor}{gray}{0.95} \usepackage{longtable} \usepackage[normalem]{ulem} \usepackage{fancyvrb} \usepackage{fancyhdr} \usepackage{graphicx} \usepackage{marginnote} \renewcommand{\@cite}[1]{#1} \renewcommand*{\marginfont}{\itshape\footnotesize} \def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif} \pagestyle{fancy} \usepackage[pdftitle={Parasitic Infection as a Risk Factor for Childhood Asthma in Upper Egypt}, pdfauthor={}]{hyperref} \hyperbaseurl{} \paperwidth210mm \paperheight297mm \def\@pnumwidth{1.55em} \def\@tocrmarg {2.55em} \def\@dotsep{4.5} \setcounter{tocdepth}{3} \clubpenalty=8000 \emergencystretch 3em \hbadness=4000 \hyphenpenalty=400 \pretolerance=750 \tolerance=2000 \vbadness=4000 \widowpenalty=10000 \renewcommand\section{\@startsection {section}{1}{\z@}% {-1.75ex \@plus -0.5ex \@minus -.2ex}% {0.5ex \@plus .2ex}% {\reset@font\Large\bfseries}} \renewcommand\subsection{\@startsection{subsection}{2}{\z@}% {-1.75ex\@plus -0.5ex \@minus- .2ex}% {0.5ex \@plus .2ex}% {\reset@font\Large}} \renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}% {-1.5ex\@plus -0.35ex \@minus -.2ex}% {0.5ex \@plus .2ex}% {\reset@font\large}} \renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}% {-1ex \@plus-0.35ex \@minus -0.2ex}% {0.5ex \@plus .2ex}% {\reset@font\normalsize}} \renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}% {1.5ex \@plus1ex \@minus .2ex}% {-1em}% {\reset@font\normalsize\bfseries}} \def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt} \@tempdima 1.5em \begingroup \parindent \z@ \rightskip \@pnumwidth \parfillskip -\@pnumwidth \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par \endgroup} \def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}} \def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}} \def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}} \def\l@subparagraph{\@dottedtocline{5}{10em}{5em}} \@ifundefined{c@section}{\newcounter{section}}{} \@ifundefined{c@chapter}{\newcounter{chapter}}{} \newif\if@mainmatter \@mainmattertrue \def\chaptername{Chapter} \def\frontmatter{% \pagenumbering{roman} \def\thechapter{\@roman\c@chapter} \def\theHchapter{\roman{chapter}} \def\thesection{\@roman\c@section} \def\theHsection{\roman{section}} \def\@chapapp{}% } \def\mainmatter{% \cleardoublepage \def\thechapter{\@arabic\c@chapter} \setcounter{chapter}{0} \setcounter{section}{0} \pagenumbering{arabic} \setcounter{secnumdepth}{6} \def\@chapapp{\chaptername}% \def\theHchapter{\arabic{chapter}} \def\thesection{\@arabic\c@section} \def\theHsection{\arabic{section}} } \def\backmatter{% \cleardoublepage \setcounter{chapter}{0} \setcounter{section}{0} \setcounter{secnumdepth}{2} \def\@chapapp{\appendixname}% \def\thechapter{\@Alph\c@chapter} \def\theHchapter{\Alph{chapter}} \appendix } \newenvironment{bibitemlist}[1]{% \list{\@biblabel{\@arabic\c@enumiv}}% {\settowidth\labelwidth{\@biblabel{#1}}% \leftmargin\labelwidth \advance\leftmargin\labelsep \@openbib@code \usecounter{enumiv}% \let\p@enumiv\@empty \renewcommand\theenumiv{\@arabic\c@enumiv}% }% \sloppy \clubpenalty4000 \@clubpenalty \clubpenalty \widowpenalty4000% \sfcode`\.\@m}% {\def\@noitemerr {\@latex@warning{Empty `bibitemlist' environment}}% \endlist} \def\tableofcontents{\section*{\contentsname}\@starttoc{toc}} \parskip0pt \parindent1em \def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}} \newenvironment{reflist}{% \begin{raggedright}\begin{list}{} {% \setlength{\topsep}{0pt}% \setlength{\rightmargin}{0.25in}% \setlength{\itemsep}{0pt}% \setlength{\itemindent}{0pt}% \setlength{\parskip}{0pt}% \setlength{\parsep}{2pt}% \def\makelabel##1{\itshape ##1}}% } {\end{list}\end{raggedright}} \newenvironment{sansreflist}{% \begin{raggedright}\begin{list}{} {% \setlength{\topsep}{0pt}% \setlength{\rightmargin}{0.25in}% \setlength{\itemindent}{0pt}% \setlength{\parskip}{0pt}% \setlength{\itemsep}{0pt}% \setlength{\parsep}{2pt}% \def\makelabel##1{\upshape ##1}}% } {\end{list}\end{raggedright}} \newenvironment{specHead}[2]% {\vspace{20pt}\hrule\vspace{10pt}% \phantomsection\label{#1}\markright{#2}% \pdfbookmark[2]{#2}{#1}% \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}% }{} \def\TheFullDate{2021 2021-03-15 (revised: 6 Year 2021 15 March 2021)} \def\TheID{\makeatother } \def\TheDate{2021 2021-03-15} \title{Parasitic Infection as a Risk Factor for Childhood Asthma in Upper Egypt} \author{}\makeatletter \makeatletter \newcommand*{\cleartoleftpage}{% \clearpage \if@twoside \ifodd\c@page \hbox{}\newpage \if@twocolumn \hbox{}\newpage \fi \fi \fi } \makeatother \makeatletter \thispagestyle{empty} \markright{\@title}\markboth{\@title}{\@author} \renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@ \belowdisplayskip \abovedisplayskip \abovedisplayshortskip \z@ plus2\p@ \belowdisplayshortskip 4\p@ plus2\p@ minus2\p@ \def\@listi{\leftmargin\leftmargini \topsep 2\p@ plus1\p@ minus1\p@ \parsep 2\p@ plus\p@ minus\p@ \itemsep 1pt} } \makeatother \fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm} \fancyhf{} \setlength{\headheight}{14pt} \fancyhead[LE]{\bfseries\leftmark} \fancyhead[RO]{\bfseries\rightmark} \fancyfoot[RO]{} \fancyfoot[CO]{\thepage} \fancyfoot[LO]{\TheID} \fancyfoot[LE]{} \fancyfoot[CE]{\thepage} \fancyfoot[RE]{\TheID} \hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true} \fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}} \date{} \usepackage{authblk} \providecommand{\keywords}[1] { \footnotesize \textbf{\textit{Index terms---}} #1 } \usepackage{graphicx,xcolor} \definecolor{GJBlue}{HTML}{273B81} \definecolor{GJLightBlue}{HTML}{0A9DD9} \definecolor{GJMediumGrey}{HTML}{6D6E70} \definecolor{GJLightGrey}{HTML}{929497} \renewenvironment{abstract}{% \setlength{\parindent}{0pt}\raggedright \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}} \vskip16pt \textcolor{GJBlue}{\large\bfseries\abstractname\space} }{% \vskip8pt \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}} \vskip16pt } \usepackage[absolute,overlay]{textpos} \makeatother \usepackage{lineno} \linenumbers \begin{document} \author[1]{Alameldin M. Abdallah MD} \author[2]{Randa E.Abd-Elkader MD} \author[3]{Doaa A.Yones MD} \renewcommand\Authands{ and } \date{\small \em Received: 4 February 2021 Accepted: 1 March 2021 Published: 15 March 2021} \maketitle \begin{abstract} Background: Asthma and allergic diseases are serious public health problems in many middle and low-income countries. We examined the relationship between parasitic infection and the development and severity of asthma among children living in Assiut Governorate, Upper Egypt.Methods: A cross sectional study was conducted on 140 children suffering from bronchial asthma (78 males and 62 females) aged from 5 to 14 years attending Assiut University Children Hospital. As well as 70 apparently healthy children with matched age and sexas controls. Beside meticulous history taking and clinical examination all patients and controls undergone; pulmonary function test, stool analysis, antibodies to Toxocara canis, antibodies to Ascaris lumbricoides,IL-5 level and Leukotriene E4.Results: Ascaris lumbricoides and Toxocara canis infections were detected in sera of 26 (18.6%), 26 (18.6%) patients respectively, whereas Giardia infection was detected in stool of 28 (20%) of patients. Among patients infected with Ascaris 15,9, and 2 patients had severe, moderate and mild asthma respectively. \end{abstract} \keywords{} \begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) \textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark} \end{textblock*} \begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) \textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}} \end{textblock*} \let\tabcellsep& \par Abstract-Background: Asthma and allergic diseases are serious public health problems in many middle and lowincome countries. We examined the relationship between parasitic infection and the development and severity of asthma among children living in Assiut Governorate, Upper Egypt.\par Methods: A cross sectional study was conducted on 140 children suffering from bronchial asthma (78 males and 62 females) aged from 5 to 14 years attending Assiut University Children Hospital. As well as 70 apparently healthy children with matched age and sexas controls. Beside meticulous history taking and clinical examination all patients and controls undergone; pulmonary function test, stool analysis, antibodies to Toxocara canis, antibodies to Ascaris lumbricoides,IL-5 level and Leukotriene E4.\par Results: Ascaris lumbricoides and Toxocara canis infections were detected in sera of 26 (18.6\%), 26 (18.6\%) patients respectively, whereas Giardia infection was detected in stool of 28 (20\%) of patients. Among patients infected with Ascaris 15,9, and 2 patients had severe, moderate and mild asthma respectively. While among patients infected with Toxocara 13,10, and 3 patients had severe, moderate and mild asthma respecively., As regard patients infected with Giardia 15,12 and1 patients had severe, moderate and mild asthma respectively. Among controls Giardia infection was detected in stool of 4 children (2.8\%). Among controls Giardia infection was detected in stool of 4 children (2.8\%).\par Conclusion: Infection with Ascaris, Toxocara and Giardia is more common among asthmatic children so infection with these parasites may be a risk factor for bronchial asthma among Upper Egyptian children. \section[{Briefpoints}]{Briefpoints}\par What is known: The multidimensional relationship between parasitic infections and asthma. and atopy.\par The immunomodulatory effects of some parasites and their protective effects upon asthma.\par A.lumbricoides eggs were associated with an increased prevalence of asthma.\par What is to add: Infection with Ascaris, Toxocara and Giardia is more common among asthmatic children than healthy children.\par Infection with these parasites may be a risk factor for development of bronchial asthma among Upper Egyptian children.\par Infection with these parasites may be a risk factor for increased asthma severity among these asthmatic children. \section[{I.}]{I.}\par Background sthma as one of the most common allergic diseases causes major public health problem in many developed and developing countries. Asthma is characterized by chronic inflammation of the airways and it is one of the most common diseases among children worldwide. Asthma affects 300 million people worldwide \hyperref[b0]{1)} .\par What is known The multidimensional relationship between parasitic infections and asthma. and atopy has been previously reported in many studies \hyperref[b1]{2)} . However, the association between parasitic infection and childhood asthma and atopy remains controversial \hyperref[b2]{3)} .\par The immunomodulatory effects of some parasites and their protective effects upon asthma had been addressed in many studies. On the other hand A. lumbricoides eggs were associated with an increased prevalence of asthma and anti-Ascaris IgE had been reported to be associated with an increased risk of asthma symptoms \hyperref[b3]{4)} .\par Human toxocariasis is a cosmopolite helminthic zoonosis caused by Toxocara canis and Toxocara cati, which are common roundworms of dogs and cats, respectively \hyperref[b4]{5)} . It has been reported that an increased risk of wheeze in some populations may be associated Toxocara infections and that may be caused by the host response to the parasite or by parasite-enhanced Th2 responses to aeroallerges \hyperref[b5]{6)} .\par Activation of Th2-type immune response which takes place in giardiasis and proved by enhanced IgE production pointed to and confirmed its association with allergy. Also IgE production is larger and more severe in allergy-complicated giardiasis than that of uncomplicated cases \hyperref[b6]{7)} .\par The aim of this study was to assess the relationship between certain parasitic infection and the development and severity of asthma among children living in Assiut Governorate, Upper Egypt.\par What is to add Infection with Ascaris, Toxocara and Giardia is more common among asthmatic children so infection with these parasites may be a risk factor for bronchial asthma among Upper Egyptian children. \section[{II.}]{II.} \section[{Materials and Methods}]{Materials and Methods}\par A cross-sectional descriptive study was performed which included 140 children with persistent bronchial asthma (78 males and 62 females) recruited at Assiut University Children Hospital, during the period from January, 2015 to January, 2016. Their ages were ranging from 5 to 14 years. As well as 70 apparently healthy children with matched age and sex were participated as controls. \section[{Inclusion criteria}]{Inclusion criteria}\par Agreement to participate; recurrent episodes of coughing, wheezing and breathlessness, especially if aggravated or triggered by exposure to inhaled allergens, viral infection or exercise and relieved by the use of bronchodilators, corticosteroids or subcutaneous epinephrine. Children should not take anti-parasitic medication in the previous 6 months and provided three samples for parasite tests on alternate days. \section[{Exclusion criteria}]{Exclusion criteria}\par Not meeting all inclusion criteria, other causes of wheezy chest such as: tuberculosis, foreign body inhalation, bronchiectasis, bronchopneumonia or any other anatomic or congenital malformations As regard the severity of asthma, we classified patients into 3 groups according to the Global Initiative for Asthma 2002 \hyperref[b7]{8)} . Group I: 20 patients had mild persistent asthma (12 males and 8 females). \section[{All cases and controls included in the study}]{All cases and controls included in the study}\par Group II: 60 patients had moderate persistent asthma (34 males and 28 females).\par Group III: 60 patients had severe persistent asthma (32 males and 26 females). \section[{a) Stool Examination}]{a) Stool Examination}\par We collected stool samples from all participants in sterile clean stool plastic disposable cups with lids labeled with the patient's serial number, name, age, and sex, group of BA and date of collection. Within half an hour all collected samples were examined parasitologically. We used iodine and lactophenol cotton blue for direct wet smear. Then, fomol-ether sedimentation was done to the stool samples and examined. \section[{b) Urinary Leukotriene E4}]{b) Urinary Leukotriene E4}\par Urinary LTE4 levels were assessed using the commercially available enzyme immunoassay (Cayman Chemical; AnnArbor, MI, USA). \section[{c) Blood Samples}]{c) Blood Samples}\par We collected blood samples from the participants by venipuncture. Cellular assay (AEC) was performed (Eosinophilia corresponded to levels above 400/mm3), then the serum samples collected were stored at -70ºC until the serological analysis. \section[{d) Total IgE levels}]{d) Total IgE levels}\par We used ELISA to measure total IgE levels where levels above 200 IU/mL were considered high. All samples were measured in duplicate. \section[{e) Human IL-5 Level Assay}]{e) Human IL-5 Level Assay}\par Human enzyme-linked immunosorbent assay kitare used to measureIL-5 levels (Biosource International, Inc., Camarillo, California, USA), according to the manufacturer's instructions. The lowest level of detection of IL-5 was 2 pg/mL. The intra-assay coefficient of variation was 7.4\%, and the inter-assay coefficient of variation was 10\%. \section[{f) Detection of Ascaris lumbricoides Infection in seology}]{f) Detection of Ascaris lumbricoides Infection in seology}\par We measured specific IgE levels against Ascaris by the CAP-FEIA fluoro enzyme immunoassay method (Phadia AB, Uppsala, Sweden). \section[{g) Detection of Toxocara canis Infection in serology}]{g) Detection of Toxocara canis Infection in serology}\par Were prepared excretory/secretory antigens from laboratory cultivated second stage larvae of T. canis according to the method of Sugan et al. \hyperref[b8]{9)} .The antigen was stored at -70ºC until used as a crude antigen. We used ELISA technique to detect IgG against T. canis according to Van {\ref Kanpen 10)} . ELISA plates (Flow Lab. Cat. No., 76-321-05) were coated by the prepared antigen. \section[{h) Statistical analysis}]{h) Statistical analysis}\par We used SPSS statistics version 22 (IBM Corporation, NY, USA) to analyze our data. Values were expressed as means and standard deviation (SD). Qualitative variables were presented as number (n) and percentage (\%). We used Chi-square test to compare qualitative variables between groups. Unpaired t-test and Mann-Whitney "U" tests were used to compare quantitative variables. Anti-Ascaris IgE was classified into quartiles based on the distribution of the study participants. \section[{III.}]{III.} \section[{Results}]{Results}\par Regarding pulmonary functions, all groups of patients showed significantly lower PEFR\% and FEV 1 \% than controls but only FEV 1 \% was insignificantly lower in mild group than controls. Regarding AEC, all patients showed significantly higher values than controls. IL-5 was significantly higher in different groups of patients than controls. Furthermore, asthmatic patients whatever collectively or subgroups showed significantly higher urinary LTE 4 levels than controls (Table {\ref 1}). {\ref 2}) Patients with severe and moderate asthma showed significantly lower PEFR\% and FEV 1 \% than mild patients and also severe patients showed significantly lower PEFR\% and FEV 1 \% than moderate patients.\par As regard AEC, serum IL-5 and urinary LTE 4 , severe and moderate asthmatics showed significantly higher values than mild patients. Also, severe patients showed significantly higher values compared to moderate patients. {\ref 4}) Regarding pulmonary functions, no significant difference was found between patients who were positive and those who were negative regarding Ascaris infection whereas, both groups showed significantly lower values of PEFR\% and FEV 1 \% compared to controls.\par Regarding AEC, patients with positive Ascaris infection showed significantly higher value than those with negative Ascaris infection. Both groups showed significantly higher values of AEC compared to controls. Regarding serum IL-5 and urinary LTE 4 , patients who were positive for Ascaris infection showed significantly higher values than those with negative Ascaris infection. Furthermore, both groups showed significantly higher values of serum IL-5 and urinary LTE 4 compared to controls. Table (5) Regarding pulmonary function, no significant difference was found between patients with positive and negative Toxocara infection whereas, both groups showed significantly lower values of PEFR\% and FEV 1 \% compared to controls.\par Regarding AEC, patients who were positive for Toxocara infection showed significantly higher value than those with negative Toxocara infection. Both groups showed significantly higher values of AEC compared to controls. Regarding serum IL-5 and urinary LTE 4 , patients who were positive for Toxocara infection showed significantly higher values than those with negative Toxocara infection. Furthermore, both groups showed significantly higher values of serum IL-5 and urinary LTE 4 compared to controls. \section[{Discussion}]{Discussion}\par Asthma is a chronic lung disease characterized by reversible airway obstruction, inflammation, and bronchial hyperresponsiveness \hyperref[b10]{11)} In this study, the relationship between Ascaris lumbricoides, Toxocara canis, Giardia lamblia infections and development and severity of childhood asthma has been studied As regard the association of parasitic infections and bronchial asthma, ascariasis were detected in the sera of 26 patients (18.6\%) and toxocariasis showed similar occurrence, whereas giardiasis was detected in the stools of 28 patients (20\%). On the other hand only giardiasis was detected in stools of 4 (2.8\%) of controls. It is possible for these parasites to be important risk factors in our communities. Our study revealed that parasitic infections with Ascaris, Toxocara and Giardia were more common among severely asthmatic children than among moderately and mildly asthmatics. This was supported by the finding of significantly higher levels of AEC, urinary LTE4 and IL-5 in Ascaris, Toxocara and Giardia positive asthmatics than negative ones. Also, pulmonary functions were insignificantly lower in the earlier than the latter (Table {\ref 4, 5, 6}).\par These results were in line with previous studies who reported the increased prevalence of parasitic infections and possible influence of parasitic infections on the development and severity of allergic conditions in the tropical environment \hyperref[b11]{12,}\hyperref[b12]{13)} .\par Our results were in agreement with systematic review and met analysis of 30 cross-sectional studies found that A. lumbricoids infection appeared to increase asthma risk \hyperref[b13]{14)} .\par Previous studies have provided conflicting evidence regarding relationship between parasitic infections and development of asthma. These studies showed that helminth infection can inhibit \hyperref[b14]{15)} , cause \hyperref[b15]{16)} or is unrelated to asthma \hyperref[b16]{17)} . The role of anti-Ascaris IgE in the development of asthma is not clear. One possible explanation for the relationship is that elevated anti-Ascaris IgE levels are associated with larval migration after re-infection, as Ascaris migrates through the lungs during maturation and causes pulmonary infiltrates of Th2 immunity and episodic airway obstruction associated with wheezing \hyperref[b17]{18)} . Repeated Ascaris infections and larval migration due to high rate of infection could increase the risk of asthma symptoms. Another explanation is that anti-Ascaris IgE acts as IgE specific to common inhaled aero-antigens directly triggering mast cell activation \hyperref[b18]{19)} . This finding was supported by two other studies \hyperref[b19]{20,}\hyperref[b20]{21)} . The third explanation is that the higher anti-Ascaris IgE levels in the wheezing group simply mean that atopic children produce more anti-Ascaris IgE in response to Ascarisinfection \hyperref[b21]{22)} . Parallel to this observation, Heukelbach et al. reported that exposure to Toxocara infection was suggested to be a possible risk factor for asthma \hyperref[b22]{23)} . One good explanation for that is, Toxocara species can cause allergy (asthma) in man by liberation of larval excretory/secretory antigens. Moreover, Toxocara was found to induce polyclonal activation of IgE producing B-cells as well as peripheral and tissue eosinophilia \hyperref[b23]{24)} . these phenomena are commonly occured with IgE mediated diseases such as allergy.\par There is hypothesis that many zoonotic helminth infections cannot develop to maturity in the human host and therefore, larvae may migrate for prolonged periods in the tissues. Examples are infections with Toxocara spp, Ascaris suum, and dog hookworms. Such infections cause allergic type syndromes such as cutaneous and visceral larva migrans \hyperref[b24]{25)} . Damage of these tissues can be caused by allergic inflammation directed against the migrating larvae associated with failure of immune regulation during such infections probably because host and parasite have not coevolved.\par Our results were in line with Di Prisco et al. 26) who found that Giardia lamblia parasitized children showed significantly higher levels of both total and specific serum IgE antibodies against allergens compared both with the non-parasitized group and those infected with parasites other than Giardia. The investigators concluded that there was a clear relation between giardiasis and allergy, possibly because infection by this protozoan enhanced sensitization towards food antigens, due to increased antigen penetration through damaged intestinal mucosa.\par It has been reported that activation of the immune system takes occurs in giardiasis. It is wider and more severe in allergy-complicated giardiasis than that of uncomplicated cases, most probably due to noninvasive character of G. lamblia. Enhanced IgE production pointed to Th2-type immune response and confirms its association with allergy 6) .\par V. \section[{Conclusion}]{Conclusion}\par Ascaris, Toxocara and Giardia infections are more common among asthmatic children compared to healthy children and they were significantly associated with the disease severity therefore, infection with these parasites may be a risk factor for the development and \begin{figure}[htbp] \noindent\textbf{(} \par \begin{longtable}{P{0.22230769230769232\textwidth}P{0.06701923076923076\textwidth}P{0.1495673076923077\textwidth}P{0.06947115384615385\textwidth}P{0.08009615384615384\textwidth}P{0.06783653846153845\textwidth}P{0.10216346153846154\textwidth}P{0.03432692307692308\textwidth}P{0.02860576923076923\textwidth}P{0.02860576923076923\textwidth}} \tabcellsep I\tabcellsep II\tabcellsep III\tabcellsep IV\tabcellsep V\tabcellsep \tabcellsep \multicolumn{2}{l}{P.value}\tabcellsep \\ \tabcellsep Patients (n: 140)\tabcellsep Mild patients\tabcellsep patients\tabcellsep Severe patients\tabcellsep Controls (n: 70)\tabcellsep \multicolumn{4}{l}{I vs V II vs V III vs V IV vs V}\\ \tabcellsep \tabcellsep (n:20)\tabcellsep (n:60)\tabcellsep (n: 60)\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\ 1-Pulmonary functions:\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\ -PEFR (\%)\tabcellsep 57.540\tabcellsep 71.800±\tabcellsep 61.933±\tabcellsep 48.400\tabcellsep 98.350\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.000\\ (mean ± SD)\tabcellsep ± 15.058\tabcellsep 14.551\tabcellsep 9.958\tabcellsep ± 14.075\tabcellsep ± 0.587\tabcellsep HS\tabcellsep HS\tabcellsep HS\tabcellsep HS\\ -FEV 1 (\%)\tabcellsep 62.140\tabcellsep 85.900\tabcellsep 67.967\tabcellsep 48.400\tabcellsep 94.300\tabcellsep 0.000\tabcellsep 0.206\tabcellsep 0.000\tabcellsep 0.000\\ (mean ± SD)\tabcellsep ± 15.554\tabcellsep ± 6.350\tabcellsep ± 5.236\tabcellsep ± 10.516\tabcellsep ±19.850\tabcellsep HS\tabcellsep NS\tabcellsep HS\tabcellsep HS\\ 3-A.E.C\tabcellsep 731.930\tabcellsep 332.600\tabcellsep 643.467\tabcellsep 953.500\tabcellsep 121.950\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.000\\ (mean ± SD)\tabcellsep ± 244.377\tabcellsep ± 100.603\tabcellsep ± 90.239\tabcellsep ± 122.081\tabcellsep ± 51.635\tabcellsep HS\tabcellsep HS\tabcellsep HS\tabcellsep HS\\ 4-IL-5 (pg/ml)\tabcellsep 46.3\tabcellsep 13.300\tabcellsep 26.850\tabcellsep 74.333\tabcellsep 6.725\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.000\\ (mean ± SD)\tabcellsep ±31.7\tabcellsep ± 3.683\tabcellsep ± 4.957\tabcellsep ± 30.335\tabcellsep ± 3.952\tabcellsep HS\tabcellsep HS\tabcellsep HS\tabcellsep HS\\ 5-LTE 4 (pg/ml)\tabcellsep 394.9\tabcellsep 110.125\tabcellsep 269.038\tabcellsep 656.333\tabcellsep 35.222\tabcellsep 0.001\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.000\\ (mean ± SD)\tabcellsep ±287.2\tabcellsep ±49.441\tabcellsep ± 47.010\tabcellsep ± 259.756\tabcellsep ± 5.044\tabcellsep MS\tabcellsep HS\tabcellsep HS\tabcellsep HS\\ \multicolumn{2}{l}{PEFR: Peak Expiratory Flow Rate}\tabcellsep \multicolumn{4}{l}{A.E.C: Absolute Eosinophilic Count}\tabcellsep \multicolumn{3}{l}{HS: Highly significant P<0..001)}\tabcellsep \\ \multicolumn{5}{l}{FEV1: Forced Expiratory Volume in 1 second ABG: Arterial Blood Gases}\tabcellsep \tabcellsep \multicolumn{3}{l}{NS: Non sngificant (P>0.05)}\tabcellsep \\ IL-5: Interleukin-5\tabcellsep \tabcellsep \multicolumn{3}{l}{S: Significant (P<0.05)}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\ LTE4: Leukotriene E4\tabcellsep \tabcellsep \multicolumn{4}{l}{MS: Moderately significant (P<0.005)}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \end{longtable} \par \caption{\label{tab_1}Table ( 1}\end{figure} \begin{figure}[htbp] \noindent\textbf{(} \par \begin{longtable}{} \end{longtable} \par \caption{\label{tab_2}Table (}\end{figure} \begin{figure}[htbp] \noindent\textbf{(} \par \begin{longtable}{P{0.5382472137791287\textwidth}P{0.08009118541033435\textwidth}P{0.11023302938196555\textwidth}P{0.034447821681864235\textwidth}P{0.06545086119554205\textwidth}P{0.013779128672745694\textwidth}P{0.007750759878419452\textwidth}} \multicolumn{6}{l}{Table (3): Prevalence of parasitic infection among the examined asthmatic patients and controls}\\ Parasite\tabcellsep \tabcellsep Patients (n)\tabcellsep (n:140) (\%)\tabcellsep Controls (n)\tabcellsep (70) (\%)\\ Ascaris lumbricoides\tabcellsep \tabcellsep (26):\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 15 severe,\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 9 moderate,\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 2 mild\tabcellsep 18.6\tabcellsep 0\tabcellsep 0\\ Toxocara canis\tabcellsep \tabcellsep (26)\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 13 severe\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 10 moderate\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 3 mild\tabcellsep 18.6\tabcellsep 0\tabcellsep 0\\ Giardia lamblia\tabcellsep \tabcellsep 28\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 15 severe\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 12 moderate\tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep 1 mild\tabcellsep 20\tabcellsep 4\tabcellsep 2.8\\ Polyparasitism\tabcellsep \tabcellsep 0\tabcellsep 0\tabcellsep 0\tabcellsep 0\\ \multicolumn{6}{l}{2): Pulmonary functions, A.E.C., serum IL-5 and urinary LTE4 of asthmatic children in relation to severity}\tabcellsep D D D D )\\ \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep (\\ I\tabcellsep \tabcellsep II\tabcellsep III\tabcellsep \\ \multicolumn{2}{l}{Mild patients}\tabcellsep Moderate\tabcellsep \tabcellsep \\ (n 20)\tabcellsep \tabcellsep patients\tabcellsep patients\tabcellsep \\ \tabcellsep \tabcellsep (n: 60)\tabcellsep (n:60)\tabcellsep \\ PEFR: Peak Expiratory Flow Rate\tabcellsep \multicolumn{3}{l}{A.E.C: Absolute Eosinophilic Count}\tabcellsep \multicolumn{2}{l}{HS: Highly significant (P<0..001)}\\ \multicolumn{3}{l}{FEV1: Forced Expiratory Volume in 1 second ABG: Arterial Blood Gases}\tabcellsep \tabcellsep \multicolumn{2}{l}{NS: Non sngificant (P>0.05)}\\ IL-5: Interleukin-5\tabcellsep \multicolumn{2}{l}{S: Significant (P<0.05)}\tabcellsep \tabcellsep \\ LTE4: Leukotriene E4\tabcellsep \multicolumn{3}{l}{MS: Moderately significant (P<0.005)}\tabcellsep \\ \multicolumn{3}{l}{Table (3) Among the studied patients Ascaris}\tabcellsep \tabcellsep \\ \multicolumn{3}{l}{lumbricoides and Toxocara infections showed similar}\tabcellsep \tabcellsep \\ \multicolumn{3}{l}{occurrence where they were detected in sera of 26}\tabcellsep \tabcellsep \\ \multicolumn{3}{l}{(18.6\%), whereas Giardia infection was detected in}\tabcellsep \tabcellsep \end{longtable} \par {\small\itshape [Note: F © 2021 Global Journals Parasitic Infection as a Risk Factor for Childhood Asthma in Upper Egypt Moderate Severe stools of 28(20\%) of patients. Among 26 patients infected with Ascaris 15 patients have severe asthma, 9 patients have moderate asthma and 2 patients have mild asthma while among 26 patients infected with]} \caption{\label{tab_3}Table (}\end{figure} \begin{figure}[htbp] \noindent\textbf{(} \par \begin{longtable}{} \end{longtable} \par \caption{\label{tab_4}Table (}\end{figure} \begin{figure}[htbp] \noindent\textbf{(} \par \begin{longtable}{P{0.1316371681415929\textwidth}P{0.12317477876106195\textwidth}P{0.12035398230088495\textwidth}P{0.206858407079646\textwidth}P{0.08180309734513273\textwidth}P{0.09966814159292035\textwidth}P{0.048893805309734514\textwidth}P{0.037610619469026545\textwidth}} \tabcellsep \tabcellsep I\tabcellsep II\tabcellsep III\tabcellsep \tabcellsep P. value\\ \tabcellsep \tabcellsep Patients with +ve Ascaris\tabcellsep patients with -ve Ascaris infection by\tabcellsep Controls (n : 70)\tabcellsep I vs III\tabcellsep II vs III\tabcellsep I vs II\\ \tabcellsep \tabcellsep infection by\tabcellsep serology\tabcellsep \tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep serology\tabcellsep (n:114)\tabcellsep \tabcellsep \tabcellsep \\ \tabcellsep \tabcellsep (n : 26)\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\ 1-\tabcellsep Pulmonary\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\ \tabcellsep functions:\tabcellsep 45.385\tabcellsep 58.260\tabcellsep 98.350\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.406\\ \tabcellsep -PEFR (\%)\tabcellsep ± 11.057\tabcellsep ± 15.822\tabcellsep ± 0.587\tabcellsep HS\tabcellsep HS\tabcellsep NS\\ \tabcellsep (mean ± SD)\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\ \tabcellsep -FEV 1 (\%)\tabcellsep 54.846\tabcellsep 63.810\tabcellsep 94.300\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.060\\ \tabcellsep (mean ± SD)\tabcellsep ± 12.096\tabcellsep ± 15.860\tabcellsep ± 19.850\tabcellsep HS\tabcellsep HS\tabcellsep NS\\ \tabcellsep 3-A.E.C\tabcellsep 888.000\tabcellsep 696.330\tabcellsep 121.950\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.010\\ \tabcellsep (mean ± SD)\tabcellsep ± 249.733\tabcellsep ± 230.814\tabcellsep ± 51.635\tabcellsep HS\tabcellsep HS\tabcellsep S\\ \tabcellsep 4-IL-5 (pg/ml)\tabcellsep 62.769\tabcellsep 41.272\tabcellsep 6.725\tabcellsep 0.000\tabcellsep 0.000\tabcellsep 0.031\\ \tabcellsep (mean ± SD)\tabcellsep ± 37.468\tabcellsep ± 30.332\tabcellsep ± 3.951\tabcellsep HS\tabcellsep HS\tabcellsep S\\ \tabcellsep 5-LTE 4 (pg/ml)\tabcellsep 665.833\tabcellsep 340.950\tabcellsep 35.222\tabcellsep 0.000\tabcellsep 0.001\tabcellsep 0.009\\ \tabcellsep (mean ± SD)\tabcellsep ± 308.584\tabcellsep ± 253.548\tabcellsep ± 5.044\tabcellsep HS\tabcellsep MS\tabcellsep MS\\ \multicolumn{3}{l}{PEFR: Peak Expiratory Flow Rate}\tabcellsep \multicolumn{5}{l}{A.E.C: Absolute Eosinophilic Count HS: Highly significant (P<0..001)}\\ \multicolumn{5}{l}{FEV1: Forced Expiratory Volume in 1 second ABG: Arterial Blood Gases}\tabcellsep \multicolumn{3}{l}{NS: Non sngificant (P>0.05)}\\ \multicolumn{2}{l}{IL-5: Interleukin-5}\tabcellsep \tabcellsep \multicolumn{2}{l}{S: Significant (P<0.05)}\tabcellsep \multicolumn{3}{l}{MS: Moderately significant (P<0.005)}\\ \multicolumn{2}{l}{LTE4: Leukotriene E4}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \end{longtable} \par \caption{\label{tab_5}Table ( 4}\end{figure} \begin{figure}[htbp] \noindent\textbf{(} \par \begin{longtable}{P{0.41027227722772275\textwidth}P{0.24195544554455442\textwidth}P{0.19777227722772278\textwidth}} \multicolumn{3}{l}{Parasitic Infection as a Risk Factor for Childhood Asthma in Upper Egypt}\\ IV.\tabcellsep \tabcellsep \\ \tabcellsep (n:114)\tabcellsep \\ \tabcellsep \tabcellsep D D D D ) F\\ \tabcellsep \tabcellsep (\\ (mean ± SD)\tabcellsep \tabcellsep \\ PEFR: Peak Expiratory Flow Rate\tabcellsep A.E.C: Absolute Eosinophilic Count\tabcellsep HS: Highly significant (P<0..001)\\ FEV1: Forced Expiratory Volume 1 second\tabcellsep ABG: Arterial Blood Gases\tabcellsep NS: Non sngificant (P>0.05)\\ IL-5: Interleukin-5\tabcellsep S: Significant (P<0.05)\tabcellsep \\ LTE4: Leukotriene E4\tabcellsep MS: Moderately significant\tabcellsep \\ \tabcellsep \tabcellsep © 2021 Global Journals\end{longtable} \par \caption{\label{tab_6}Table ( 5}\end{figure} \footnote{© 2021 Global JournalsParasitic Infection as a Risk Factor for Childhood Asthma in Upper Egypt} \backmatter {\ref 6}\par ) Regarding pulmonary functions, Giardia positive patients showed significantly lower PEFR \% and FEV 1 \% than patients with negative Giardia infection. Furthermore, both groups showed significantly lower PEFR\% and FEV 1 \% compared to controls Regarding AEC and urinary LTE 4 , patients with positive Giardia infection showed significantly higher values than patients with negative Giardia infection. Furthermore, both groups showed significantly higher values than controls. Regarding serum IL-5, patients with negative Giardia infection showed significantly higher value than patients with positive Giardia infections. Both groups showed significantly higher value than controls. \begin{bibitemlist}{1} \bibitem[Palmer et al. ()]{b14}\label{b14} ‘A lumbricoids infection is associated with increased risk of childhood asthma and atopy in rural China’. L J Palmer , J C Celedon , S T Weiss , B Wang , Z Fang , X Xu . \textit{Am J RespirCrit Care Med} 2002. 165 p. . \bibitem[Prisco et al. ()]{b24}\label{b24} ‘Association between giardiasis and allergy’. Di Prisco , M C Hagel , I Lynch , N R Jimenez , J C Rojas , R Gil , M . \textit{Ann Allergy Asthma Immunol} 1998. 81 p. . \bibitem[Leonardi-Bee et al. ()]{b12}\label{b12} ‘Asthma and current intestinal parasite infection: systematic review and meta-analysis’. J Leonardi-Bee , D Pritchard , J Britton . \textit{Am J RespirCrit Care Med} 2006. 174 p. . \bibitem[Li et al. ()]{b4}\label{b4} ‘Asthma and toxocariasis’. L Li , W Gao , X Yang , D Wu . \textit{Ann Allergy Asthma Immunol} 2014. 113 p. . \bibitem[Sharghi and Schantz]{b21}\label{b21} ‘CaramicoL Environmental exposiure to Toxocaraas a possible risk factor for asthma: A clinic-based case-control study’. N Sharghi , P M Schantz . \textit{Clinical Infections Diseases} 32 p. . \bibitem[Wu et al. ()]{b9}\label{b9} ‘Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge’. Jiang Wu , Eric A Michikokobayashi , Wei Sousa , Jiecai Liu . \textit{Molecular and cellular proteomics} 2005. 4 p. . \bibitem[Cooper et al. ()]{b16}\label{b16} ‘Effect of albendazole treatments on the prevalence of atopy in children living in communities' endemic for geohelminths parasites: a cluster randomized trial’. P J Cooper , M E Chico , M G Vaca , A L Moncayo , J M Bland , E Mafla . \textit{Lancet} 2006. 367 p. . \bibitem[Sharghi et al. ()]{b15}\label{b15} ‘Environmental exposure to Toxocara as a possible risk factor for asthma: a clinical-based case-control study’. N Sharghi , P M Schantz , L Caramico , K Ballas , B Teague , P J Hotez . \textit{Clin Infect Dis} 2001. 32 p. . \bibitem[Heukelbach and Feldmeier ()]{b22}\label{b22} ‘Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans’. J Heukelbach , H Feldmeier . \textit{Lancet Infect Dis} 2008. 8 p. . \bibitem[Souza et al. ()]{b6}\label{b6} ‘Giardia lamblia and respiratory allergies: a study of children from an urban area with a high incidence of protozoan infections’. V M Souza , I R Sales , D M Peixoto , V M Costa , J A Rizzo , A R Silva . \textit{J Pediatr (Rio J)} 2012. 88 p. . \bibitem[Gobal Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention. National Institutes of Health and National Heart, Lung and Blood Institute Available at: WWW. Gina asthma (2002)]{b7}\label{b7} ‘Gobal Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention. National Institutes of Health and National Heart, Lung and Blood Institute’. \textit{Available at: WWW. Gina asthma}, 2002. April 2002. \bibitem[Takeuchi et al. ()]{b2}\label{b2} ‘High titre of anti-Ascaris immunoglobulin E associated with bronchial asthma symptoms in 5-year-old rural Bangladeshi children’. H Takeuchi , K Zaman , J Takahashi , M Yunus , H R Chowdhury , S E Arifeen . \textit{ClinExp Allergy} 2008. 38 p. . \bibitem[Rubinsky-Elefant et al. ()]{b23}\label{b23} ‘Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms’. G Rubinsky-Elefant , C E Hirata , J H Yamamoto . \textit{Ann Trop Med Parasitol} 2010. 104 p. . \bibitem[Porcel et al. ()]{b19}\label{b19} ‘IgE mediated hypersensitivity to common earthworm. Characterization of allergies involved’. S L Porcel , C Camara , A Rodriguez , C Fletes , S Jiménez , E Rodríguez . \textit{Allergy and Clinical Immunology International. J World Allergy Org} 2005. 17 p. . \bibitem[Scrivener et al. ()]{b13}\label{b13} ‘Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study’. S Scrivener , H Yemaneberhan , M Zebenigus , D Tilahun , S Girma , AliS . \textit{Lancet} 2001. 358 p. . \bibitem[Bundy ()]{b1}\label{b1} ‘New initiatives in the control of helminths’. Dap Bundy . \textit{Trans Roy Soc Trop Med Hyg} 1990. 84 p. . \bibitem[Woolcock ()]{b10}\label{b10} ‘Peat JK Evidence for the increase in asthma worldwide’. A J Woolcock . \textit{Ciba Found Symp} 2005. 206 p. . \bibitem[Pinelli et al. ()]{b3}\label{b3} ‘Prevalence of antibodies against Ascaris and its association with allergic manifestations in 4-year-old children in The Netherlands: the PIAMA birth cohort study’. E Pinelli , S M Willers , D Hoek , H A Smit , L M Kortbeek , M Hoekstra . \textit{Eur J ClinMicrobiol Infect Dis} 2009. 28 p. . \bibitem[Jarrett and Miller ()]{b18}\label{b18} ‘Production and activities of IgE in helminth infection’. E E Jarrett , H R Miller . \textit{Prog Allergy} 1982. 32 p. . \bibitem[Spillman ()]{b17}\label{b17} ‘Pulmonary Ascariasis in tropical communities’. R K Spillman . \textit{Am J Trop Med Hyg} 1975. 24 p. . \bibitem[Lynch et al. ()]{b20}\label{b20} ‘Relationship between helminth infection and IgE response in atopic and non-atopic children in a tropical environment’. N R Lynch , I A Hagel , M E Palenque , Di Prisco , M C Escudero , J E Corao , LA . \textit{J Allergy ClinImmunol} 1998. 101 p. . \bibitem[Bayraktar et al. ()]{b5}\label{b5} ‘Serum cytokine changes in Turkish children infected with Giardia lamblia with and without allergy: Effect of metronidazole treatment’. M R Bayraktar , N Mehmet , R Durmaz . \textit{Acta Trop} 2005. 95 p. . \bibitem[Braman ()]{b0}\label{b0} ‘The global burden of asthma’. S S Braman . \textit{Chest} 2006. 130 p. . \bibitem[Reid et al. ()]{b11}\label{b11} ‘The year in respiratory medicine’. P Reid , R Fergusson , A Hill , T Mackay , J Simpson . \textit{Atlas Medical Publishing Ltd} 2004. p. . \bibitem[Van Kanpen et al. ()]{b8}\label{b8} ‘Toxocarol Larva migrans; diagnosis and prevalence in the Netherlands. National Institute of public Health’. F Van Kanpen , The Ba Bilthon , Netherland . \textit{P.O. Box} 1983. 1. \end{bibitemlist} \end{document}